Clinical Trials Browser

Phase 2 × Breast Neoplasms, Male × Receptor Protein-Tyrosine Kinases × Clear all

NCT01570036 2020-12-02

Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax

Phase 2 Completed

275 enrolled 23 charts

Breast Neoplasms, Breast Neoplasms, Male